Morketing·每日监测10.29:泡泡玛特回应业绩大跌;字节辟谣“群演数据喂大模型”;宇树科技前三季度净利增逾270%

摘要

【摘要】 每日营销资讯

一、品牌


泡泡玛特回应业绩大跌


针对第三季度业绩大幅下滑,泡泡玛特在业绩电话会上进行了详细回应。首席运营官司德将业绩下滑归因于2025年同期异常的高基数与二手市场“炒娃”热度的回落。他指出,去年三季度是公司历史上单季销售最高的季度,业务集中爆发导致今年同比压力巨大,且去年三季度线上渠道因抢购和炒货热度极高,基数异常偏高;今年二级市场炒娃热度明显回落,这是线上渠道下滑幅度更大的最主要原因。


霸王茶姬与Monchhichi推出联名合作


10月28日,霸王茶姬宣布与玩偶品牌Monchhichi推出联名,上新“橙巧可可”、“云漫可可”、“可可黑森林”三款饮品及“橙巧可可gelato”冰淇淋。据品牌介绍,三款饮品均使用100%原产地进口可可。此次联名同步推出主题杯袋、抽拉小卡、贴纸套组及冰箱贴等,部分周边随指定套餐提供。线下,品牌将在上海、广州、深圳、成都、杭州等数十个城市开设可可茶工坊主题门店,消费者到店购买任意可可系列饮品,可参与活动赢取限定徽章。


尊尼获加黑牌系列宣布ROSÉ成为全球品牌代言人


尊尼获加黑牌系列宣布ROSÉ成为全球品牌代言人,双方将围绕音乐、文化与风味展开合作。此次合作以尊尼获加黑牌与黑宝石两款威士忌为核心,推出四款ROSÉ灵感特调,搭配苹果、青柠、蜜瓜、椰子水等原料,呈现不同的风味组合。


杨国福官宣帕梅拉为全球品牌推荐官


近日,杨国福麻辣烫官宣国外运动博主帕梅拉成为杨国福麻辣烫的全球品牌推荐官,二者推出了 54321 均衡自选公式——5种蔬菜+4种蛋白质+3种碳水+2种菌藻+1个汤底,把麻辣烫包装成了健康餐。


二、互联网


宇树科技上市后首份业绩出炉,前三季度净利增逾270%


10月28日,宇树科技披露上市后首份业绩报告。财报显示,2026年第三季度,公司实现营业收入6.65亿元,同比增长69.93%;归母净利润1.13亿元,同比下降17.37%。此外,前三季度累计实现营业收入18.17亿元,同比增长55.71%;归母净利润3.87亿元,同比增长270.54%,盈利增速显著高于收入增速。值得注意的是,研发投入大幅扩张或为单季利润承压的主因。公司第三季度研发投入1.27亿元,同比增长249.58%;前三季度累计研发投入2.63亿元,同比增长191.48%,研发强度持续抬升。截至10月28日收盘,宇树科技股价上涨8.74%,最新总市值达2815亿元。


字节辟谣“群演数据喂大模型”


10月28日,豆包公关负责人刘星发文称,“横店与字节合作,将15万名群演的肖像和声音喂给字节大模型”的传言严重失实。刘星表示,横店影视AI服务平台项目,其实是希望建设一套公共数字基础设施,把影视基地实景等资产做成高质量数据集,帮助剧组更高效地选景、筹备和拍摄,也降低中小影视企业使用AI的门槛,让更多创作者有条件把作品做好。


红果短剧上线防沉迷提醒机制


近日,红果短剧上线“休息提醒”和“睡眠提醒”两项机制。用户看剧超过一定时长,或在深夜时段打开红果短剧时即可触发。据介绍,“休息提醒”在用户看剧超过一定时长后触发:在剧集播放页,屏幕上方会出现“是时候休息下啦”的提示;在推荐页,用户则会刷到一条提醒视频,熟悉的短剧角色对着镜头,提醒用户放下手机,休息一下。“睡眠提醒”则面向深夜时段仍在看剧的用户。目前,提醒机制正逐步覆盖更多用户。


OpenAI因ChatGPT建议减药致华人工程师离世而遭起诉


据媒体10月28日报道,一名住在西雅图的31岁华人女子,疑因依照ChatGPT提供的逐日减药计划,自行将抗癫痫药物逐步减量至停药后死亡。她的父母当地时间27日向旧金山高等法院提起不当致死诉讼,控告OpenAI及其CEO奥特曼(Sam Altman),指ChatGPT无照行医、提供危险且不准确的医疗建议。


据报道,死者来自中国江苏,曾在亚马逊担任软件工程师,2021年起请长期病假。她患有严重癫痫,服用多年的药物一度失效,后来改用新药,发作次数降至每月数次。她自2023年起频繁使用ChatGPT,询问感情、健康保险与身心障碍给付等问题;2025年平均每周传送逾1500则消息。OpenAI发言人普萨特里(Drew Pusateri)表示,涉案的GPT-4o已于2月13日从ChatGPT消费者应用程序下架;新模型更能辨识需要紧急处理的情况,并给予更明确的后续建议,公司也持续评估并与临床医师合作测试。他强调:“ChatGPT不能取代医疗照护。”


微信输入法上线“AI录音笔”


10月27日,微信派发文宣布,微信输入法上线“AI录音笔”功能,可将录音实时转写并整理为结构化网页。该功能支持修正错别字、过滤无意义口语,并结合上下文梳理逻辑与重点,还可根据录音内容匹配图表、图示及交互原型。用户可从手机端键盘工具栏或微信输入法App进入,电脑端则支持通过快捷键、Mac顶部菜单栏或Windows工具栏调用。


三、广告片


天猫双11发布AI品牌片《更因你们值得》


近日,天猫围绕“更因你们值得”主题,发布了一支全AI制作的品牌片。短片以运动、旅行、亲子陪伴等生活场景展开:商品最初以不带品牌标识的形态出现,随着人物使用,adidas、M·A·C、Babycare、北面、HOKA等品牌标识逐渐浮现,呈现商品与使用者日常生活的联系。



四、洞察趋势


携程发布《2026年可持续旅行消费者报告》


携程集团发布《2026年可持续旅行消费者报告》,覆盖全球29个市场近九千名受访者。报告显示,34.1%的受访者愿意选择乘坐沿途风景优美的列车出行,这往往代表着更低碳的出行方式;31.9%的受访者愿意选择入住,践行可持续理念的低碳环保标签酒店,能够让旅程的体验更美好。


美股三大指数集体收涨,大型科技股涨跌不一


10月28日收盘,美股三大指数集体上涨,纳指涨0.27%,道指涨0.19%,标普500指数涨0.28%。大型科技股涨跌不一,SK海力士涨超13%,甲骨文涨超10%,闪迪涨超7%,英特尔、谷歌涨超1%,亚马逊小幅上涨;Meta、英伟达跌超1%,苹果、奈飞、特斯拉、微软小幅下跌。热门中概股多数下跌,新东方跌超12%,腾讯音乐、哔哩哔哩、知乎、网易、名创优品、老虎证券、拼多多跌超1%;百度、理想汽车涨超1%。


五、海外营销


Marketbridge 收购 Channel99,一家专注于B2B的DSP


Who doesn’t know that doleful tune, “The agencies they are a-changin’.”


That’s not exactly how Bob Dylan sang it in the original, but it’s not wrong.


One such agency is Marketbridge, a 35-year-old B2B marketing firm that’s been a recent acquirer of agency and consultancy services businesses. Marketbridge added to its portfolio on Tuesday by announcing its acquisition of Channel99, a B2B advertising and attribution tech company.


Terms of the deal were not disclosed.


Channel99 was founded in 2022 by Chris Golec, who was also founder and CEO of incumbent B2B demand-side platform Demandbase. But Channel99 isn’t quite a DSP, at least not in the open web programmatic sense. It spans platforms instead; Microsoft/LinkedIn, the Googleverse, Meta and other hubs of business media and influence.


One important gap that Channel99 fills in this services stack, according to Marketbridge CEO Bob Ray, is as an agentic search analytics provider. It helps its clients answer queries like, “How does one company’s services rank in LLM chatbot responses compared to competitors?” or “How do paid media and marketing tactics in other channels affect performance in agentic or generative search platforms?”


These are the types of questions that Channel99 has software to address, Ray said. The next step will be creating an attribution framework to help understand how agentic performance contributes to sales or conversions, much like a media buyer would measure any other channel.


医疗营销科技公司OptimizeRx正在转向程序化


Maria Cipicchio sits at the intersection of some of the world’s most dizzying three-letter acronyms.

She’s the SVP of strategic market intelligence at OptimizeRx, a software subscription service for healthcare providers, which plugs into their drug-prescribing and record-keeping systems. And OptimizeRx has taken its next big step into the world of programmatic through a new partnership this month with The Trade Desk.


OptimizeRx’s inventory is all within HCP electronic health records (EHRs). The company’s inventory is all strictly within the doctor’s log-in portal at the point of care, and its advertisers to date are all pharma brands.


“We knew that we needed to enter the [programmatic] space very carefully,” Cipicchio told AdExchanger.


OptimizeRx started working with DeepIntent earlier this year on a programmatic banner ad partnership. Doctors or healthcare providers (or HCPs) see these ads in their software UIs when they log in to set up a prescription or copay card for a patient.


Programmatic units, though, are loaded with more concerns, she said. For one thing, pharma marketers don’t want to have their ads placed alongside actual patient data. That’s not a government rule, but something that’s important to those marketers.


Then there are OptimizeRx’s concerns. The ad creatives must all be vetted, Cipicchio said. Aside from making sure there’s nothing inappropriate or off-base, it’s important not to serve an ad that feels errant or misleading to the doctor. The ad must always focus on relevant healthcare data regarding its product.


“But the buyer doesn’t ever see that aspect of it, which is one of the beauties of programmatic,” she said.


Morketing授权发布

收藏 收藏 0
资讯

Morketing电商营销8.21监测:腾讯追加投资“易久批”8000万美元;网易考拉内部高管会:融资进展一切顺利

资讯

Morketing每日监测10.11:百丽国际旗下滔搏昨日上市,市值近570亿港元;沃尔玛计划在近期上线小程序;海外优衣库业务首超日本国内业务;未来十年全球将诞生40个新数字化巨头

评论 · 0

请先后参与评论